Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - NET INCOME
Net Income ANAB - AnaptysBio, Inc.
-164 M
LAST VALUE
-68.25%
2 YEAR CAGR
-21.55%
5 YEAR CAGR
-40.28%
10 YEAR CAGR